Advertisement
The prevalence of HIV-related mortality is still highest among blacks

CDC: HIV-Related Mortality Disparities Persisting for Blacks

0
And, blacks account for 45 percent of CDC-funded testing events, 54.9 percent of newly positive
Only about one in two U.S. nursing home workers receive an annual flu vaccination

Flu Vaccination Rates for Nursing Home Staff Too Low

0
Many nursing home workers have mistaken beliefs about the flu and vaccination
Only about 40 percent of the nearly $2.9 billion in international aid pledged to the Ebola outbreak in West Africa had reached the hard-hit countries of Guinea

Fewer Than Half of Ebola Pledges Have Reached Area in Need

0
Just 40 percent of pledged aid has been received by hardest hit countries
Adults 65 and older need two pneumococcal vaccines to better protect them from sepsis

Two Pneumococcal Vaccines Advised for Seniors

0
ACIP advises both Prevnar 13, Pneumovax 23 vaccines for adults 65 and older

January 2015 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for January 2015. This roundup includes the...
Bacteria may offer a new way to treat cancer

CIO: Bacteria Could Be Useful in Fight Against Cancer

0
Weakened strain of Clostridium novyi-NT bacteria thrives in low oxygen environment
Patient engagement initiatives can decrease costs without sacrificing quality care

Patient Engagement Can Cut Costs, Improve Outcomes

0
Initiatives can decrease hospital visits, cut morbidity and mortality, up treatment adherence
A review of the data suggests that the antiviral drug oseltamivir (Tamiflu) shortens the length of flu symptoms by about a day

Review: Oseltamivir Shortens Flu Duration by About a Day

0
And reduces the risk of flu-related complications such as pneumonia
The United States has seen more cases of measles in January than it usually does in an entire year

CDC: Measles Cases in January Top Typical Load for Entire Year

0
Spread driven largely by outbreak that started at Disney theme parks in California in December
Early results suggest an experimental Ebola vaccine triggers an immune response and is safe to use. The findings were published online Jan. 28 in the New England Journal of Medicine.

Results Appear Promising for Experimental Ebola Vaccine

0
Vaccine works against Zaire strain of Ebola currently circulating in West Africa